tbuckley/cabot-search huggingface dataset:
Діагностична значимість сироваткових маркерів фіброзу печінки у хворих на HCV-інфекцію
Authors: S.L. Melanich
Journal: GASTROENTEROLOGY (2013)

У роботі розглядаються діагностичні можливості використання сироваткових маркерів фіброзу печінки у хворих на хронічну HCV-інфекцію. Проведення спеціальних тестів (AAR, APRI, Forns’ score, FibroIndex, FIB-4, MDA, GUCI, SHASTA, k ЛН, k ММР-1 та k ЛН/ММР-1) із використанням прямих та непрямих маркерів фіброзу печінки є альтернативним неінвазивним, доступним методом діагностики фіброзу печінки.
Patients’ understanding of cellulitis and views about how best to prevent recurrent episodes: mixed‐methods study in primary and secondary care
Authors: E.J. Teasdale, A. Lalonde, I. Muller, J. Chalmers, P. Smart, J. Hooper, M. El‐Gohary, K.S. Thomas, M. Santer
Journal: British Journal of Dermatology (2018)

Cellulitis is a common painful infection of the skin and underlying tissues that recurs in approximately one-third of cases. The only proven strategy to reduce the risk of recurrence is long-term, low-dose antibiotics. Given current concerns about antibiotic resistance and the pressure to reduce antibiotic prescribing, other prevention strategies are needed.To explore patients' views about cellulitis and different ways of preventing recurrent episodes.Adults aged ≥ 18 years with a history of first-episode or recurrent cellulitis were invited through primary care, hospitals and advertising to complete a survey, take part in an interview or both.Thirty interviews were conducted between August 2016 and July 2017. Two hundred and forty surveys were completed (response rate 17%). Triangulation of quantitative and qualitative data showed that people who have had cellulitis have wide-ranging beliefs about what can cause cellulitis and are often unaware of risk of recurrence or potential strategies to prevent recurrence. Enhanced foot hygiene, applying emollients daily, exercise and losing weight were more popular potential strategies than the use of compression stockings or long-term antibiotics. Participants expressed caution about long-term oral antibiotics, particularly those who had experienced only one episode of cellulitis.People who have had cellulitis are keen to know about possible ways to prevent further episodes. Enhanced foot hygiene, applying emollients daily, exercise and losing weight were generally viewed to be more acceptable, feasible strategies than compression or antibiotics, but further research is needed to explore uptake and effectiveness in practice.
Tepotinib in patients with advanced non-small lung cancer (NSCLC) and MET exon 14-skipping mutations: Phase II data
Authors: H. Sakai, E. Felip, A.B. Cortot, R. Veillon, F. Griesinger, J. Patel, L. Horn, J. Mazieres, J. De Castro Carpeno, M. Morise, T. Sakamoto, R. Bruns, J. Scheele, J. Straub, P. Paik
Journal: Annals of Oncology (2018)
Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trial
Authors: David M. Charytan, Jonathan Himmelfarb, T. Alp Ikizler, Dominic S. Raj, Jesse Y. Hsu, J. Richard Landis, Amanda H. Anderson, Adriana M. Hung, Rajnish Mehrotra, Shailendra Sharma, Daniel E. Weiner, Mark Williams, Marcelo DiCarli, Hicham Skali, Paul L. Kimmel, Alan S. Kliger, Laura M. Dember, Alan Kliger, David M. Charytan, Emily Robinson, Mark Williams, Daniel E. Weiner, Ezra Aurien-Blajeni, Maria Angeles Cinelli, Tayyaba Nizam, Sookyung Rim, Paul Seok, Caroline Smith, Jasmine Rollins, Dominic Raj, Renu Regunathan-Shenk, Shailendra Sharma, Ali Ramezani, Sarah Andrews, Michelle Dumadag, Christina Franco, Maria Wing, Jonathan Himmelfarb, Rajnish Mehrotra, Lisa Anderson, Lori Linke, Linda Manahan, T. Alp Ikizler, Adriana Hung, Kerri Cavanaugh, Cindy Booker, Brigitte Brannon, Adrienne Clagett, Charles Ellis, Laura Dember, J. Richard Landis, Amanda Anderson, Jesse Hsu, Denise Cifelli, Shawn Ballard, Marie Durborow, Tamara Howard, Natalie Kuzla, Lisa Nessel, Ann Tierney, Hicham Skali, Scott Solomon, Aria Rad, Marcelo Di Carli, Masha Gaber, Courtney Foster, Paul Kimmel, John Kusek
Journal: Kidney International (2018)
Endoscopic ultrasound-guided hepaticogastrostomy combined with antegrade stenting using a double bare covered metal stent
Authors: Takeshi Ogura, Nobu Nishioka, Akira Miyano, Rieko Kamiyama, Kazuhide Higuchi
Journal: Endoscopy (2018)

Endoscopic ultrasound-guided hepaticogastrostomy (EUS-HGS) has been indicated for failed endoscopic retrograde cholangiopancreatography (ERCP) [1] [2]. Recently, to obtain a longer duration of stent patency or avoid adverse events, EUS-HGS combined with antegrade stenting (EUS-HGAS) has been reported [3] [4].In this procedure, an uncovered, self-expandable, metal stent (UCSEMS) is usually used to avoid stent dislocation. However, compared with a fully covered, self-expandable, metal stent (FCSEMS), longer stent patency may not be achieved [5]. A novel, double bare, partially covered, self-expandable, metal stent (D-FCSEMS, EGIS Biliary Stent; S&G Biotech Inc., Yongin-si, Korea) ([Fig. 1]) has become available in Japan. This stent has low axial force compared with conventional FCSEMS, and high radial force compared with conventional UCSEMS. Therefore, this stent may be suitable for EUS-HGAS. Herein, we describe technical tips for EUS-HGAS using the D-FCSEMS ([Video 1]).
Acute Respiratory Failure in the Adult
Authors: H. Pontoppidan, B. Geffin, E. Lowenstein
Journal: New England Journal of Medicine (1972)

Effect of Mechanical Ventilation and Airway Pressures on Circulation and Blood Gas ExchangeThe ventilatory pattern is defined by: the inspiratory and expiratory flow rates and pressures, including plateaus (periods of zero flow at end-inspiration or expiration); tidal volume; duration of inspiration and expiration; and frequency and magnitude of hyperinflations. The optimal pattern for artificial ventilation varies from patient to patient according to the nature of the underlying disease. Ventilators must therefore provide means for altering ventilatory patterns over a wide range, features now incorporated in most volume preset ventilators. Although the need for adequate carbon dioxide removal must be . . .
Microparticle-associated tissue factor activity: A link between cancer and thrombosis?
Authors: Margot Tesselaar, Fred Romijn, Irma Van der Linden, Frans Prins, Rogier Bertina, Susanne Osanto
Journal: Cancer Research (2006)

3637  Background: Cancer, in particular mucinous adenocarcinomas, is associated with an increased risk of venous thromboembolism (VTE). Tissue factor (TF), a transmembrane-receptor protein and initiator of coagulation, plays a central role in the paradigm that clotting and tumor growth form a vicious circle, in which hypercoagulability facilitates the aggressive biology of cancer and vice versa. Expression of TF is associated with poor differentiation of tumors and poor prognosis. We initiated a study in cancer patients, to find out whether microparticles (MP) derived from malignant epithelial cells, may directly initiate blood coagulation locally or at distant sites via TF expressed on these MP and play a critical role in the development of the hypercoagulability Patients & Methods: MP were isolated from peripheral blood samples obtained from healthy subjects, and unselected cancer patients, i.e. patients with primary breast carcinoma (before and after surgery), with metastatic breast carcinoma and with pancreatic carcinoma. Tissue factor procoagulant activity associated with isolated MP was studied by factor VIIa dependent generation of factor Xa. MP were examined by flow cytrometric phenotyping, and electron and confocal immunofluorescence laser scanning microscopical examination. Results: Compared to 37 healthy sujects, significantly increased levels of MP-associated TF activity were found in patients with disseminated breast and pancreatic cancer. Pancreatic (n=5) and breast cancer patients (n=2) who presented with clinically manifest venous thrombosis had a 18-fold increase in MP-associated TF activity as compared to healthy subjects or 6 subjects with idiopathic VTE (P
Re-Examination of 2017 ELN Risk Classification By a Cohort of 739 De Novo aml Patients in Taiwan: Co-Occurring Poor-Risk Mutations May Further Predict Outcome in FLT3-ITD Patients
Authors: Sheng-Chuan Huang, Hsin-An Hou, Cheng-Hong Tsai, Wen-Chien Chou, Jih-Luh Tang, Ming Yao, Bor-Sheng Ko, Feng-Ming Tien, Yuan-Yeh Kuo, Mei-Hsuan Tseng, Chien-Chin Lin, Chien-Ting Lin, Ming-Kai Chuang, Tai-Chung Huang, Chien-Yuan Chen, Szu-Chun Hsu, Chieh-Lung Cheng, Huai-Hsuan Huang, Sheng-Chieh Chou, Shang-Ju Wu, Shang-YI Huang, Hwei-Fang Tien
Journal: Blood (2018)
Lymphoma Virome Dynamics Revealed By Cell-Free DNA Sequencing
Authors: Joseph G Schroers-Martin, Andrea Garofalo, Joanne Soo, Michael C. Jin, David M. Kurtz, Lieselot Buedts, Ulrich Dührsen, Andreas Hüttmann, Anne Ségolène Cottereau, Michel Meignan, Olivier Casasnovas, Jason R. Westin, Gianluca Gaidano, Davide Rossi, Mark Roschewski, Wyndham H. Wilson, Ranjana H Advani, Peter Vandenberghe, Maximilian Diehn, Kiran Khush, Ash A. Alizadeh
Journal: Blood (2018)
Antimicrobial use in European long-term care facilities: results from the third point prevalence survey of healthcare-associated infections and antimicrobial use, 2016 to 2017
Authors: Enrico Ricchizzi, Katrien Latour, Tommi Kärki, Rossella Buttazzi, Béatrice Jans, Maria Luisa Moro, Olivia Aya Nakitanda, Diamantis Plachouras, Dominique L Monnet, Carl Suetens, Pete Kinross
Journal: Eurosurveillance (2018)

Antimicrobials are commonly prescribed and contribute to the development of antimicrobial resistance in long-term care facilities (LTCFs). In 2010, the European Centre for Disease Prevention and Control initiated point prevalence surveys (PPS) of healthcare-associated infections and antimicrobial use in European LTCFs, performed by external contractors as the Healthcare-Associated infections in Long-Term care facilities (HALT) projects. Here, we investigated prevalence and characteristics of antimicrobial use and antimicrobial stewardship indicators in European LTCFs in 2016-17. Twenty-four European Union/European Economic Area (EU/EEA) countries, the former Yugoslav Republic of Macedonia and Serbia participated in the third PPS in European LTCFs. Overall, 4.9% (95% confidence interval: 4.8-5.1) of LTCF residents in the EU/EEA participating countries received at least one antimicrobial. The most commonly reported Anatomical Therapeutic Chemical (ATC) groups were beta-lactam antibacterials/penicillins (J01C), other antibacterials (J01X) (e.g. glycopeptide antibacterials, polymyxins), quinolones (J01M), sulfonamides and trimethoprim (J01E), and other beta-lactams (J01D). Urinary tract infections and respiratory tract infections were the main indications for antimicrobial prescription. This PPS provides updated and detailed information on antimicrobial use in LTCFs across the EU/EEA that can be used to identify targets for future interventions, follow-up of these interventions and promote prudent use of antimicrobials in European LTCFs.
Looking beyond Mortality in Transplantation Outcomes
Authors: Daniela J. Lamas, Joshua R. Lakin, Anil J. Trindade, Andrew Courtwright, Hilary Goldberg
Journal: New England Journal of Medicine (2018)

Despite an increasing emphasis on patient-centered outcomes in medicine, transplant centers do not systematically report information on health-related quality of life, nor are such measures incorporated into algorithms for organ allocation or program assessment.
THU0216 Serum cxcl16 levels in rf+/acpa+rheumatoid arthritis patients before and after treatment with dmards
Authors: R. Ramamoorthy, T.N. Tamilselvam, B. Kumar
Journal: Annals of the Rheumatic Diseases (2018)

Background  Rheumatoid arthritis (RA) is characterised by profound mononuclear cell (MNC) recruitment into synovial tissue (ST). Studies have shown that chemokine CXCL16 is a premier MNC recruiter in RA. CXCL16 contributes to chronic inflammation, since it is highly expressed in RA synovial fluid (SF), is a potent chemoattractant for mononuclear cells (MNCs) in vitro, and is chemotactic for peripheral blood mononuclear cells (PBMCs) to RA ST in vivo. Hence treatment for RA will reflect change in serum CXCL16 levels  Objectives  The aim of this study was to analyse the change of serum chemokine level of CXCL16, in patients with either RF +or ACPA +rheumatoid arthritis (RA), by DMARDs treatment.  Methods  This was a prospective interventional study done in a tertiary care centre. 31 patients with RA were recruited for a period of 12 months. Serum CXCL16 levels were assayed in them along with other baseline investigations. The patients were treated with DMARDs. CXCL16 levels post treatment were measured after 6 months. For comparison another group of age and sex matched controls was taken (n=18) and their serum CXCL16 was also recorded. The serum CXCL16 levels were correlated with disease activity.  Results  After treatment with conventional DMARDs 26 patients showed lowering of mean serum CXCL16 levels from 56.07 pg/ml to 21.79 pg/ml (62% reduction) after 6 months. The patients who showed inadequate response to conventional DMARD treatment (n=5) underwent therapy with biological DMARDs(TNF-α blocker) which reduced their CXCL16 levels from 63.81 pg/ml to 12.36 pg/ml (80.6% reduction) in subsequent 6 months. There was a corresponding improvement in the disease activity of RA. Lowering of CXCL16 was found to correlate positively with improvement of symptoms and lowering of disease activity  Conclusions  DMARDs treatment significantly lowered the serum levels of CXCL16 in patients with RA. CXCL16 is one of the crucial chemokines regulated by DMARDs treatment  Reference  [1] Ruth JH, Haas CS, Park CC, et al. CXCL16 Mediated cell recruitment to Rheumatoid Arthritis Synovial Tissue and Murine Lymph Nodes is dependent upon the MAPK pathway. Arthritis and Rheumatism2006;765–778. doi:10.1002/art.21662  Disclosure of Interest  None declared
Ribociclib (RIB) + endocrine therapy (ET) in Japanese women with hormone receptor-positive (HR+), HER2-negative (HER2–) advanced breast cancer (ABC)
Authors: N. Masuda, S. Noguchi, T. Ishikawa, T. Aruga, S.J. Kim, T. Toyama, T. Saeki, M. Saito, T. Yamanaka, J. Watanabe, S. Nakamura, M. Takahashi, K. Inoue, I. Gounaris, Y. Han, T.S. Samant, M. Gazdoiu, Y. Ito
Journal: Annals of Oncology (2018)
Effect of two pedometer-based walking interventions on long-term health outcomes: a study using routine primary care data
Authors: Tess Harris, Elizabeth Limb, Fay Hosking, Iain Carey, Steve DeWilde, Cheryl Furness, Charlotte Wahlich, Shaleen Ahmad, Sally Kerry, Peter Whincup, Christina Victor, Michael Ussher, Steve Iliffe, Ulf Ekelund, Julia Fox-Rushby, Judith Ibison, Derek Cook
Journal: The Lancet (2018)
Clinical, Cytogenetic and Immunophenotype Distribution of Adult Acute Lymphoblastic Leukemia Among Latinos — a Report from a Large Single Institution Cohort in Southern California
Authors: Elisa Quiroz, Rebecca Nelson, Vinod A. Pullarkat, Ibrahim Aldoss, Thomas Slavin, Eduardo Magalhães Rego, Guido Marcucci, Dan Douer
Journal: Blood (2018)
Real-world evidence of the safety and effectiveness of regorafenib in patients with metastatic colorectal cancer (mCRC) from Taiwan: A subgroup analysis from the prospective, observational CORRELATE study
Authors: K.-H. Yeh, T.-S. Yang, T.-C. Hsu, W.T.-L. Chen, H.-H. Chen, H.-W. Teng, B.-W. Lin, F.-C. Kuan, F.-F. Chiang, C.-W. Duann, Y.-S. Li, S. Fiala-Buskies, M. Ducreux, J.-Y. Wang
Journal: Annals of Oncology (2018)
Incidental Pulmonary Nodules Detected on CT Images
Authors: Irsk J. Anderson, Andrew M. Davis
Journal: JAMA (2018)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
A Case-Control Study to Compare the Survival Benefits of Patients Who Suffer from Peripheral T-Cell Lymphoma (PTCL) Treated with Chidamide, a Histone Deacetylase Inhibitor, in China with a Historical Matched Cohort of Patients Treated with Conventional Therapy in Taiwan: Survival Advantage Is Demonstrated
Authors: Bor-Sheng Ko, Su-Peng Yeh, Hsiao-Wen Kao, Yuan-Bin Yu, Shyh-Tyan Ou, Cheng-Shyong Chang
Journal: Blood (2018)
Single-cell transcriptional analysis reveals ILC-like cells in zebrafish
Authors: Pedro P. Hernández, Paulina M. Strzelecka, Emmanouil I. Athanasiadis, Dominic Hall, Ana F. Robalo, Catherine M. Collins, Pierre Boudinot, Jean-Pierre Levraud, Ana Cvejic
Journal: Science Immunology (2018)

Analyses of immune cells in rag1-deficient zebrafish led to the discovery of innate lymphoid cells in teleosts.
Доцільність використання урсодезоксихолевої кислоти в лікуванні хворих на неалкогольну жирову хворобу печінки: клінічний випадок
Authors: Ye.S. Sirchak
Journal: GASTROENTEROLOGY (2018)

Неалкогольна жирова хвороба печінки (НАЖХП) посідає провідне місце серед хронічних захворювань печінки. Поряд з цим патогенез НАЖХП на сьогодні не повністю вивчений. Деякі автори пропонують вважати НАЖХП однією зі складових метаболічного синдрому (МС), розглядаючи її як печінковий прояв МС. У статті подано сучасні погляди на лікування хворих із НАЖХП. Також висвітлено теоретичні аспекти використання урсодезоксихолевої кислоти (УДХК) і можливості її застосування у хворих із поєднанням НАЖХП і МС. Як приклад продемонстровано доцільність і ефективність призначення УДХК пацієнту Л. із НАЖХП і МС (порушення толерантності до глюкози, артеріальна гіпертензія, ожиріння). Призначення Урсофальку хворому Л. є патогенетично обґрунтованим з огляду на гіпохолестеринемічний, цитопротекторний, антиоксидантний, антихолестатичний та інші його позитивні ефекти. УДХК може розглядатись як ефективний і безпечний препарат у лікуванні не тільки хворих на НАЖХП, а й пацієнтів із МС, захворюваннями серцево-судинної системи й ожирінням.
Transcriptome profiling of refractory atopic keratoconjunctivitis by RNA sequencing
Authors: Akira Matsuda, Yosuke Asada, Naomasa Suita, Satoshi Iwamoto, Toshiaki Hirakata, Norihiko Yokoi, Yasuyuki Ohkawa, Yukinori Okada, Takehiko Yokomizo, Nobuyuki Ebihara
Journal: Journal of Allergy and Clinical Immunology (2018)
Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma — an IMWG Research Project
Authors: Saad Z. Usmani, Antje Hoering, Michele Cavo, Jesus San Miguel, Hartmut Goldschimdt, Roman Hajek, Ingemar Turesson, Juan Jose Lahuerta, Michel Attal, Bart Barlogie, Jae Hoon Lee, Shaji Kumar, Stig Lenhoff, Gareth Morgan, S. Vincent Rajkumar, Brian G. M. Durie, Philippe Moreau
Journal: Blood Cancer Journal (2018)

multiple myeloma is considered an incurable hematologic cancer but a subset of patients can achieve long-term remissions and survival. The present study examines the clinical features of long-term survival as it correlates to depth of disease response.this was a multi-institutional, international, retrospective analysis of high-dose melphalan-autologous stem cell transplant (HDM-ASCT) eligible MM patients included in clinical trials. Clinical variable and survival data were collected from 7291 MM patients from Czech Republic, France, Germany, Italy, Korea, Spain, the Nordic Myeloma Study Group and the United States. Kaplan-Meier curves were used to assess progression-free survival (PFS) and overall survival (OS). Relative survival (RS) and statistical cure fractions (CF) were computed for all patients with available data.achieving CR at 1 year was associated with superior PFS (median PFS 3.3 years vs. 2.6 years, p < 0.0001) as well as OS (median OS 8.5 years vs. 6.3 years, p < 0.0001). Clinical variables at diagnosis associated with 5-year survival and 10-year survival were compared with those associated with 2-year death. In multivariate analysis, age over 65 years (OR 1.87, p = 0.002), IgA Isotype (OR 1.53, p = 0.004), low albumin < 3.5 g/dL (OR = 1.36, p = 0.023), elevated beta 2 microglobulin ≥ 3.5 mg/dL (OR 1.86, p < 0.001), serum creatinine levels ≥ 2 mg/dL (OR 1.77, p = 0.005), hemoglobin levels < 10 g/dL (OR 1.55, p = 0.003), and platelet count < 150k/μL (OR 2.26, p < 0.001) appeared to be negatively associated with 10-year survival. The relative survival for the cohort was ~0.9, and the statistical cure fraction was 14.3%.these data identify CR as an important predictor of long-term survival for HDM-ASCT eligible MM patients. They also identify clinical variables reflective of higher disease burden as poor prognostic markers for long-term survival.
Critical steps for initiating an animal uterine transplantation model in sheep: Experience from a case series
Authors: Angeline Favre-Inhofer, Marie Carbonnel, Aurélie Revaux, Olivier Sandra, Valérie Mougenot, Romain Bosc, Valérie Gélin, Arash Rafii, Barbara Hersant, François Vialard, Pascale Chavatte-Palmer, Christophe Richard, Jean-Marc Ayoubi
Journal: International Journal of Surgery (2018)
CNBP controls IL-12 gene transcription and Th1 immunity
Authors: Yongzhi Chen, Shruti Sharma, Patricia A. Assis, Zhaozhao Jiang, Roland Elling, Andrew J. Olive, Saiyu Hang, Jennifer Bernier, Jun R. Huh, Christopher M. Sassetti, David M. Knipe, Ricardo T. Gazzinelli, Katherine A. Fitzgerald
Journal: The Journal of Experimental Medicine (2018)

An inducible program of inflammatory gene expression is a hallmark of antimicrobial defenses. Recently, cellular nucleic acid-binding protein (CNBP) was identified as a regulator of nuclear factor-kappaB (NF-κB)-dependent proinflammatory cytokine gene expression. Here, we generated mice lacking CNBP and found that CNBP regulates a very restricted gene signature that includes IL-12β. CNBP resides in the cytosol of macrophages and translocates to the nucleus in response to diverse microbial pathogens and pathogen-derived products. Cnbp-deficient macrophages induced canonical NF-κB/Rel signaling normally but were impaired in their ability to control the activation of c-Rel, a key driver of IL-12β gene transcription. The nuclear translocation and DNA-binding activity of c-Rel required CNBP. Lastly, Cnbp-deficient mice were more susceptible to acute toxoplasmosis associated with reduced production of IL-12β, as well as a reduced T helper type 1 (Th1) cell IFN-γ response essential to controlling parasite replication. Collectively, these findings identify CNBP as important regulator of c-Rel-dependent IL-12β gene transcription and Th1 immunity.
Abstract 13991: Development of Integrated Backscatter Intravascular Ultrasound for Tissue Characterization of Coronary Plaques Using 60MHz Ultrasound Signals
Authors: Yuki Sahashi, Masanori Kawasaki, Misayo Hayashi, Hisaaki Komaki, Shingo Minatoguchi, Shinya Baba, Akihiro Yoshida, Takahide Nawa, Toshiki Tanaka, Takatomo Watanabe, Hiromitsu Kanamori, Kazuhiko Nishigaki, Shinya Minatoguchi
Journal: Circulation (2017)

Introduction: We previously developed integrated backscatter (IB) intravascular ultrasound (IVUS) for tissue characterization of coronary plaques using 40MHz ultrasound signals. Recently, an IVUS s...